May 10 (Reuters) - Immunovaccine Inc IMV.TO :
* Immunovaccine announces financial results for quarter ended March 31, 2017
* Net loss and comprehensive loss of $2.4 million for quarter ended march 31, 2017, up $518,000
* At March 31, 2017, immunovaccine had cash and cash equivalents of $11.8 million versus $13.5 million at Dec 31, 2016 Source text for Eikon: ID:nCCN6C9Qlb Further company coverage: IMV.TO